Equities analysts expect Acadia Healthcare Company, Inc. (NASDAQ:ACHC) to report earnings of $0.55 per share for the current quarter, according to Zacks Investment Research. Eight analysts have made estimates for Acadia Healthcare’s earnings. The lowest EPS estimate is $0.54 and the highest is $0.56. Acadia Healthcare posted earnings per share of $0.59 during the same quarter last year, which would suggest a negative year over year growth rate of 6.8%. The company is expected to issue its next earnings results on Thursday, February 22nd.

On average, analysts expect that Acadia Healthcare will report full-year earnings of $2.25 per share for the current year, with EPS estimates ranging from $2.20 to $2.44. For the next year, analysts expect that the business will post earnings of $2.50 per share, with EPS estimates ranging from $2.27 to $2.75. Zacks Investment Research’s EPS calculations are an average based on a survey of research analysts that follow Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.65 by ($0.07). Acadia Healthcare had a return on equity of 8.57% and a net margin of 6.07%. The firm had revenue of $716.70 million for the quarter, compared to analysts’ expectations of $728.86 million. During the same period last year, the company posted $0.58 earnings per share. The business’s quarterly revenue was down 2.4% on a year-over-year basis.

A number of analysts recently issued reports on the stock. Mizuho increased their price target on shares of Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a report on Friday, July 28th. BMO Capital Markets assumed coverage on shares of Acadia Healthcare in a report on Monday, October 16th. They set an “outperform” rating and a $52.00 price target on the stock. Jefferies Group LLC set a $42.00 price target on shares of Acadia Healthcare and gave the stock a “buy” rating in a report on Wednesday, October 25th. Craig Hallum reissued a “buy” rating and set a $65.00 price target (up from $52.00) on shares of Acadia Healthcare in a report on Monday, July 31st. Finally, Zacks Investment Research downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, October 2nd. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company’s stock. Acadia Healthcare currently has an average rating of “Hold” and a consensus target price of $45.15.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The original version of this news story can be accessed at https://www.watchlistnews.com/analysts-expect-acadia-healthcare-company-inc-achc-to-announce-0-55-earnings-per-share/1701233.html.

In other news, EVP Christopher L. Howard sold 53,713 shares of the stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $2,722,711.97. Following the completion of the sale, the executive vice president now directly owns 147,286 shares in the company, valued at $7,465,927.34. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, President Brent Turner sold 206,252 shares of the stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total transaction of $10,454,913.88. Following the completion of the sale, the president now owns 81,106 shares of the company’s stock, valued at $4,111,263.14. The disclosure for this sale can be found here. Insiders have sold 1,824,040 shares of company stock valued at $92,460,588 over the last 90 days. 11.10% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently modified their holdings of ACHC. BlackRock Inc. raised its position in shares of Acadia Healthcare by 27,497.3% in the first quarter. BlackRock Inc. now owns 5,145,786 shares of the company’s stock valued at $224,356,000 after buying an additional 5,127,140 shares during the last quarter. William Blair Investment Management LLC raised its position in shares of Acadia Healthcare by 1,247.4% in the second quarter. William Blair Investment Management LLC now owns 2,128,972 shares of the company’s stock valued at $105,129,000 after buying an additional 1,970,965 shares during the last quarter. Janus Henderson Group PLC acquired a new stake in shares of Acadia Healthcare in the second quarter valued at about $74,805,000. State Street Corp raised its position in shares of Acadia Healthcare by 95.2% in the second quarter. State Street Corp now owns 1,998,030 shares of the company’s stock valued at $98,667,000 after buying an additional 974,524 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Acadia Healthcare by 107.3% in the second quarter. Dimensional Fund Advisors LP now owns 1,486,643 shares of the company’s stock valued at $73,412,000 after buying an additional 769,333 shares during the last quarter.

Shares of Acadia Healthcare (NASDAQ ACHC) traded down $0.40 during midday trading on Friday, reaching $28.23. 1,420,300 shares of the company were exchanged, compared to its average volume of 1,344,452. Acadia Healthcare has a 12-month low of $27.88 and a 12-month high of $54.34. The stock has a market capitalization of $2,490.00, a P/E ratio of 12.33, a PEG ratio of 1.05 and a beta of 0.89. The company has a debt-to-equity ratio of 1.30, a current ratio of 1.36 and a quick ratio of 1.36.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.